We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBIO
5101
Valion Bio
VBIO
$709K
$5K ﹤0.01%
+2
New +$6.54K
TPB icon
5102
Turning Point Brands
TPB
$1.73B
$5K ﹤0.01%
150
-652
-81% -$22.1K
TTI icon
5103
TETRA Technologies
TTI
$1.25B
$5K ﹤0.01%
1,192
-6,952
-85% -$22.2K
UCO icon
5104
ProShares Ultra Bloomberg Crude Oil
UCO
$422M
$5K ﹤0.01%
120
-40,300
-100% -$1.3M
UEIC icon
5105
Universal Electronics
UEIC
$75.8M
$5K ﹤0.01%
175
-2,154
-92% -$74.6K
UG icon
5106
United-Guardian
UG
$33.3M
$5K ﹤0.01%
205
+65
+46% +$1.21K
UNCY icon
5107
Unicycive Therapeutics
UNCY
$150M
$5K ﹤0.01%
+384
New +$5.62K
UVE icon
5108
Universal Insurance Holdings
UVE
$1.18B
$5K ﹤0.01%
353
-320
-48% -$4.8K
UXIN
5109
Uxin Ltd
UXIN
$260M
$5K ﹤0.01%
48
-125
-72% -$14.3K
VERA icon
5110
Vera Therapeutics
VERA
$2.08B
$5K ﹤0.01%
227
-311
-58% -$6.69K
VERI icon
5111
Veritone
VERI
$139M
$5K ﹤0.01%
292
-920
-76% -$15.8K
VOD icon
5112
Vodafone
VOD
$37.2B
$5K ﹤0.01%
292
-14,770
-98% -$252K
VOT icon
5113
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
$5K ﹤0.01%
22
-6,831
-100% -$1.51M
VPL icon
5114
Vanguard FTSE Pacific ETF
VPL
$8.65B
$5K ﹤0.01%
66
– –
VRNA
5115
DELISTED
Verona Pharma
VRNA
$5K ﹤0.01%
1,031
+698
+210% +$4.06K
VRP icon
5116
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$5K ﹤0.01%
224
– –
VVX icon
5117
V2X
VVX
$2.55B
$5K ﹤0.01%
149
-116
-44% -$4.96K
YARW
5118
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$5K ﹤0.01%
8
-1
-11% -$594
WINT
5119
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
XTNT icon
5120
Xtant Medical Holdings
XTNT
$43.5M
$5K ﹤0.01%
7,116
-3,153
-31% -$2.06K
XXII
5121
22nd Century Group
XXII
$1.49M
– –
0
– –
SER icon
5122
Serina Therapeutics
SER
$42.7M
$5K ﹤0.01%
175
+132
+307% +$3.76K
OKLO
5123
Oklo
OKLO
$8.64B
$5K ﹤0.01%
449
-136
-23% -$1.33K
ATYR
5124
aTyr Pharma
ATYR
$54.2M
$5K ﹤0.01%
1,023
+998
+3,992% +$5.66K
TBCH
5125
Turtle Beach Corp
TBCH
$230M
$5K ﹤0.01%
225
-300
-57% -$6.28K
203 204
205
206 207

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.